216 related articles for article (PubMed ID: 6548718)
21. Cellular localization of müllerian inhibiting substance in the developing rat ovary.
Ueno S; Takahashi M; Manganaro TF; Ragin RC; Donahoe PK
Endocrinology; 1989 Feb; 124(2):1000-6. PubMed ID: 2643506
[TBL] [Abstract][Full Text] [Related]
22. Is Mullerian-inhibiting substance a circulating hormone in the chick-quail chimera?
Hutson JM; Donahoe PK
Endocrinology; 1983 Oct; 113(4):1470-5. PubMed ID: 6688583
[TBL] [Abstract][Full Text] [Related]
23. Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.
Kurian MS; de la Cuesta RS; Waneck GL; MacLaughlin DT; Manganaro TF; Donahoe PK
Clin Cancer Res; 1995 Mar; 1(3):343-9. PubMed ID: 9815990
[TBL] [Abstract][Full Text] [Related]
24. Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.
Catlin EA; Tonnu VC; Ebb RG; Pacheco BA; Manganaro TF; Ezzell RM; Donahoe PK; Teixeira J
Endocrinology; 1997 Feb; 138(2):790-6. PubMed ID: 9003016
[TBL] [Abstract][Full Text] [Related]
25. Absence of teratogenic effects of progesterone on the developing genital tract of the human female fetus.
Cunha GR; Taguchi O; Sugimura Y; Lawrence WD; Mahmood F; Robboy SJ
Hum Pathol; 1988 Jul; 19(7):777-83. PubMed ID: 3402971
[TBL] [Abstract][Full Text] [Related]
26. The ontogeny of Mullerian inhibiting substance in the gonads of the chicken.
Hutson J; Ikawa H; Donahoe PK
J Pediatr Surg; 1981 Dec; 16(6):822-7. PubMed ID: 6896069
[TBL] [Abstract][Full Text] [Related]
27. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
28. Experimental study of the effect of diethylstilbestrol on the development of the human female reproductive tract.
Taguchi O; Cunha GR; Robboy SJ
Biol Res Pregnancy Perinatol; 1983; 4(2):56-70. PubMed ID: 6882849
[TBL] [Abstract][Full Text] [Related]
29. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
[TBL] [Abstract][Full Text] [Related]
30. Müllerian inhibiting substance is present in embryonic testes of dogs with persistent müllerian duct syndrome.
Meyers-Wallen VN; Lee MM; Manganaro TF; Kuroda T; Maclaughlin D; Donahoe PK
Biol Reprod; 1993 Jun; 48(6):1410-8. PubMed ID: 8318594
[TBL] [Abstract][Full Text] [Related]
31. Müllerian inhibiting substance in sex-reversed dogs.
Meyers-Wallen VN; Donahoe PK; Manganaro T; Patterson DF
Biol Reprod; 1987 Nov; 37(4):1015-22. PubMed ID: 3689844
[TBL] [Abstract][Full Text] [Related]
32. Antibody against avian müllerian inhibiting substance (MIS) recognizes MIS on rat müllerian duct and human tumor cells.
Wang JJ; Teng CS
Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):267-75. PubMed ID: 2484046
[TBL] [Abstract][Full Text] [Related]
33. Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity.
Hirobe S; He WW; Lee MM; Donahoe PK
Endocrinology; 1992 Aug; 131(2):854-62. PubMed ID: 1639028
[TBL] [Abstract][Full Text] [Related]
34. [Anti-Mullerian hormone. Structure and role in sexual differentiation].
Jarmińska-Jackowiak T; Warenik-Szymankiewicz A; Trzeciak WH
Ginekol Pol; 1995 Jan; 66(1):51-8. PubMed ID: 8522216
[TBL] [Abstract][Full Text] [Related]
35. Androgen stimulation of nucleotide pyrophosphatase during mullerian duct regression.
Fallat ME; Hutson JM; Budzik GP; Donahoe PK
Endocrinology; 1984 May; 114(5):1592-8. PubMed ID: 6143657
[TBL] [Abstract][Full Text] [Related]
36. Mullerian inhibiting substance inhibits colony growth of a human ovarian carcinoma cell line.
Fuller AF; Guy S; Budzik GP; Donahoe PK
J Clin Endocrinol Metab; 1982 May; 54(5):1051-5. PubMed ID: 6895900
[TBL] [Abstract][Full Text] [Related]
37. Developmentally regulated polyadenylation of two discrete messenger ribonucleic acids for müllerian inhibiting substance.
Lee MM; Cate RL; Donahoe PK; Waneck GL
Endocrinology; 1992 Feb; 130(2):847-53. PubMed ID: 1346380
[TBL] [Abstract][Full Text] [Related]
38. Bioactivation of Müllerian inhibiting substance during gonadal development by a kex2/subtilisin-like endoprotease.
Nachtigal MW; Ingraham HA
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7711-6. PubMed ID: 8755541
[TBL] [Abstract][Full Text] [Related]
39. Expression levels of Mullerian-inhibiting substance, GATA4 and 17alpha-hydroxylase/17,20-lyase cytochrome P450 during embryonic gonadal development in two diverse breeds of swine.
McCoard SA; Wise TH; Ford JJ
J Endocrinol; 2002 Nov; 175(2):365-74. PubMed ID: 12429034
[TBL] [Abstract][Full Text] [Related]
40. Origin of anti-Müllerian hormone in bovine freemartin fetuses.
Vigier B; Tran D; Legeai L; Bézard J; Josso N
J Reprod Fertil; 1984 Mar; 70(2):473-9. PubMed ID: 6546587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
